CUE

Cue Biopharma (CUE)

Cue Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CUE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/25	22:00	GlobeNewswire Inc.	Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/11/15	06:05	GlobeNewswire Inc.	Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/11/15	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc
2024/11/15	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/11/14	22:00	GlobeNewswire Inc.	Cue Biopharma Announces Strategic Organizational Transition	NASDAQ:CUE	Cue Biopharma Inc
2024/11/12	22:00	GlobeNewswire Inc.	Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/11/09	03:30	GlobeNewswire Inc.	Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting	NASDAQ:CUE	Cue Biopharma Inc
2024/10/09	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/10/08	06:07	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CUE	Cue Biopharma Inc
2024/10/05	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/10/04	22:00	GlobeNewswire Inc.	Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting	NASDAQ:CUE	Cue Biopharma Inc
2024/09/28	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/09/28	05:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CUE	Cue Biopharma Inc
2024/09/27	12:26	GlobeNewswire Inc.	Cue Biopharma Announces Pricing of $12.0 Million Public Offering	NASDAQ:CUE	Cue Biopharma Inc
2024/09/27	12:10	GlobeNewswire Inc.	Cue Biopharma Announces Proposed Public Offering	NASDAQ:CUE	Cue Biopharma Inc
2024/09/27	05:32	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CUE	Cue Biopharma Inc
2024/09/27	05:27	GlobeNewswire Inc.	Cue Biopharma Announces Proposed Public Offering	NASDAQ:CUE	Cue Biopharma Inc
2024/09/11	05:00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CUE	Cue Biopharma Inc
2024/09/09	21:00	GlobeNewswire Inc.	Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer	NASDAQ:CUE	Cue Biopharma Inc
2024/09/06	05:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/09/06	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CUE	Cue Biopharma Inc
2024/09/04	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/09/03	21:00	GlobeNewswire Inc.	Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference	NASDAQ:CUE	Cue Biopharma Inc
2024/08/29	05:00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CUE	Cue Biopharma Inc
2024/08/20	05:05	GlobeNewswire Inc.	Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CUE	Cue Biopharma Inc
2024/08/17	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc
2024/08/15	05:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CUE	Cue Biopharma Inc
2024/08/13	21:00	GlobeNewswire Inc.	Cue Biopharma to Host Business Update Call and Webcast	NASDAQ:CUE	Cue Biopharma Inc
2024/07/26	05:05	GlobeNewswire Inc.	Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements	NASDAQ:CUE	Cue Biopharma Inc
2024/07/26	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CUE	Cue Biopharma Inc